National LTC Pharmacy Group: DIR Fees Should be Eliminated, Not “Reformed”
Senate Aging Committee Hearing on Untangling “Complex Web of Prescription Drug Prices” Provides Forum for Ongoing Discussion of Abolishing Direct and Indirect Remuneration (DIR) Fees…Read More.
Doggett Announces Ways & Means Medicare Drug-Pricing Hearing
Inside Health Policy
The House Ways & Means health subcommittee will hold a hearing on promoting competition to lower prescription drug prices in Medicare…Read More.
National LTC Pharmacy Group Praises SFC Momentum on PBM Rebate Transparency
Positive Grassley Sentiment on Greater PBM Transparency Draws Support from SCPC…Read More.
Ohio seeks $16m from UnitedHealth’s PBM for overcharging on drugs
Ohio officials are ratcheting up their closely watched battle with pharmacy benefit managers as the state attorney general is seeking nearly $16 million from OptumRx for allegedly failing to pass along discounts for generic drugs that were purchased by a state agency…Read More.
First-In-Nation Montana Bill Would Regulate PBMs Through Insurers
Inside Health Policy
A bill that takes a unique, aggressive strategy to require pharmacy benefit managers pass drug rebates through to plans was passed out of a Montana Senate committee with only Republican support…Read More.
New transparency requirements, loss of safe harbor for PBMs and drugmakers in proposed rule
The Trump administration is calling for pharmacy benefit managers to disclose to health plans the fees that they get from drug companies for administrative services as part of a bid to boost transparency among PBMs…Read More.
Trump, claiming progress in lowering drug prices, tells Congress ‘we must do more’
In his State of the Union address Tuesday, President Trump touted his administration’s work to reduce the price of prescription drugs and called on Congress to take further action…Read More.
Focus on Drug Prices Likely in State of the Union, Experts Say
It’s time for one of Washington’s favorite parlor games: guessing what the president will say in his State of the Union speech…Read More.
Trump’s New Pharmacy Benefit Manager Rebate Rule Will Reshape Prescription Drug Prices
On Thursday, U.S. Health and Human Services Secretary Alex Azar released a long-anticipated rule that could transform the prices that people pay for prescription drugs, and the broader pharmaceutical market…Read More.